CARL · NASDAQ · Medical - Healthcare Information Services

Carlsmed (CARL)

Builds personalized spine-fusion implant kits from AI-enabled surgical plans.

$14.85
vs last close−0.57 (−3.70%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue45679101213151619
Cost of revenue11222333444
Gross profit345578910121215
9911−351131519212226
Research & development03443344556
96799101115161720
Selling & marketing045767810111012
General & administrative02222335568
Other expenses000−1639000000
Operating income−5−5−68−44−6−7−9−9−9−11
000−16390011111
Interest income00000001111
Interest expense00000000000
Other non-operating income00015−3900−1−1−1−11
Income before tax−6−5−6−8−5−6−7−9−9−90
Net income from continuing operations−6−5−6−8−5−6−7−9−9−90
Other adjustments0000000000−11
Net income−6−5−6−8−5−6−7−9−9−9−11
EPS, basic−$0.21−$1.36−$1.55−$1.83−$0.18−$0.33−$1.47−$0.40−$0.25−$0.32−$0.39
EPS, diluted−$0.21−$1.36−$1.55−$1.83−$0.18−$0.33−$1.47−$0.40−$0.25−$0.32−$0.39
Weighted average shares, basic274452719521142727
Weighted average shares, diluted274452719521142727
EBITDA−6−5−6−7−4−5−6−8−8−80
Depreciation & amortization00000000000
EBIT−6−5−6−7−4−5−6−8−8−80